Literature DB >> 17917013

Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Charlotte Cunningham-Rundles1, Adina Kay Knight.   

Abstract

BACKGROUND: Common variable immune deficiency (CVID) is a clinically and immunologically heterogenous primary immune deficiency first described more than 50 years ago. The main features are hypogammaglobulinemia, recurrent infections, and other complications. While CVID is considered as a genetic immune defect, and several genes have been reported as leading to the CVID phenotype, one of the most puzzling features of CVID is the sporadic inheritance pattern and the relatively late onset. In most cases, no other family members have any immune defect. The mean age at diagnosis is between 25 and 45 years of age. These features suggest the interplay between either several or numerous genes with or without potential environmental factors.

Entities:  

Mesh:

Year:  2007        PMID: 17917013     DOI: 10.1007/s12026-007-0024-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  80 in total

Review 1.  Mapping genes underlying complex disorders: progress on IgA deficiency and common variable immunodeficiency.

Authors:  I Vorechovsky; A D Webster; L Hammarstrom
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

2.  Immune competence and switched memory B cells in common variable immunodeficiency.

Authors:  Jimmy Ko; Lin Radigan; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2005-07       Impact factor: 3.969

3.  Failure of primary and secondary T cell responses in common variable immunodeficiency.

Authors:  A Stagg; S C Knight; A D Webster; J Farrant
Journal:  Immunodeficiency       Date:  1993

4.  Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

5.  Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry.

Authors:  H Kanegane; S Tsukada; T Iwata; T Futatani; K Nomura; J Yamamoto; T Yoshida; K Agematsu; A Komiyama; T Miyawaki
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 6.  Common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

7.  Impaired proliferative response to B-lymphocyte activators in common variable immunodeficiency.

Authors:  S Cunningham-Rundles; C Cunningham-Rundles; D I Ma; F P Siegal; S Gupta; E M Smithwick; C Kosloff; R A Good
Journal:  Scand J Immunol       Date:  1982-03       Impact factor: 3.487

8.  Family studies in common variable immunodeficiency.

Authors:  I Vorechovský; J Litzman; J Lokaj; R Sobotková
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1991

9.  CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

Authors:  M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

Review 10.  Pulmonary complications of primary immunodeficiencies.

Authors:  Rebecca H Buckley
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

View more
  14 in total

Review 1.  Regulation of mucosal IgA responses: lessons from primary immunodeficiencies.

Authors:  Andrea Cerutti; Montserrat Cols; Maurizio Gentile; Linda Cassis; Carolina M Barra; Bing He; Irene Puga; Kang Chen
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

Review 2.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

Review 3.  The regulation of IgA class switching.

Authors:  Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

Review 4.  Immunodeficiencies.

Authors:  M Ballow; L Notarangelo; B Grimbacher; C Cunningham-Rundles; M Stein; M Helbert; B Gathmann; G Kindle; A K Knight; H D Ochs; K Sullivan; J L Franco
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

Review 5.  Innate signals in mucosal immunoglobulin class switching.

Authors:  Irene Puga; Montserrat Cols; Andrea Cerutti
Journal:  J Allergy Clin Immunol       Date:  2010-11       Impact factor: 10.793

6.  Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency.

Authors:  N Rezaei; A A Amirzargar; Y Shakiba; M Mahmoudi; B Moradi; A Aghamohammadi
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

7.  Common variable immunodeficiency in horses is characterized by B cell depletion in primary and secondary lymphoid tissues.

Authors:  M Julia B F Flaminio; Rebecca L Tallmadge; Cristina O M Salles-Gomes; Mary Beth Matychak
Journal:  J Clin Immunol       Date:  2008-08-02       Impact factor: 8.317

8.  Treatment of patients with immune thrombocytopenia admitted to the emergency room.

Authors:  Işıl Bavunoğlu; Ahmet Emre Eşkazan; Muhlis Cem Ar; Mahir Cengiz; Serap Yavuzer; Ayşe Salihoğlu; Şeniz Öngören; Aydın Tunçkale; Teoman Soysal
Journal:  Int J Hematol       Date:  2016-04-29       Impact factor: 2.490

Review 9.  The biology of intestinal immunoglobulin A responses.

Authors:  Andrea Cerutti; Maria Rescigno
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

10.  A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.

Authors:  Karina M Melo; Karina I Carvalho; Fernanda R Bruno; Lishomwa C Ndhlovu; Wassim M Ballan; Douglas F Nixon; Esper G Kallas; Beatriz T Costa-Carvalho
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.